Abstract:Background: Acute ischemic stroke (AIS) is an atherothrombotic disease. Trimethylamine-N-oxide (TMAO), a gut microbiota-dependent metabolite, has been shown to be proatherogenic and prothrombotic. However, the involvement of TMAO in AIS remains unclear. This study aimed to observe the dynamic changes of TMAO in AIS patients and identify the prognostic value of TMAO for major ischemic events and unfavorable functional outcomes. Methods: This study included 204 AIS patients and 108 healthy controls. Blood samples for TMAO analyses were drawn at admission, 2 and 7 days of admission. Logistic regression models and receiver operating characteristic curves were established to identify associations between TMAO levels and major ischemic events (ischemic stroke, myocardial infarction, or death from an ischemic vascular event), as well as unfavorable functional outcomes (modified Rankin Scale score >= 3), at 90 days and 12 months. Results: TMAO levels showed no significant changes before and within 24 h of AIS treatment (at admission) but decreased significantly thereafter. Elevated log(2)-transformed baseline TMAO levels were associated with increased risks of 90-day [odds ratio (OR), 2.62; 95% confidence interval (CI), 1.55-4.45; p < 0.001] and 12-month (OR, 3.59; 95% CI, 2.12-6.09; p < 0.001) major ischemic events, as well as 90-day (OR, 2.89; 95% CI, 1.46-5.71; p = 0.002) and 12-month (OR, 2.58; 95% CI, 1.50-4.46; p = 0.001) unfavorable functional outcomes, after adjustments for confounding factors. The areas under curve of baseline TMAO levels for predicting 90-day and 12-month major ischemic events were 0.72 (95% CI, 0.61-0.83; p < 0.001) and 0.76 (95% CI, 0.66-0.85; p < 0.001). Baseline TMAO levels improved the prognostic accuracy of conventional risk factors, National Institutes of Health Stroke Scale (NIHSS) score and N-terminal B-type natriuretic peptide (NT-proBNP) level. Conclusions: TMAO levels decreased with time since stroke onset. Elevated TMAO levels at an earlier period portended poor stroke outcomes, broadening the potential clinical utility of TMAO as an independent prognostic marker and therapeutic target.

[The Relationship Between Serum Asymmetric Dimethylarginine and ABCD2 Score in Transient Ischemic Attack Patients].

Abstract 276: Asymmetric Dimethylarginine is A Potential Risk Factor for Transient Ischemic Attack

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke.

Can ABCD2 Score Predict the Need for In-Hospital Intervention in Patients with Transient Ischemic Attacks?

Relations Between Plasma Asymmetric Dimethylarginine (adma) and Risk Factors for Coronary Disease

Analysis of correlation between oxidized low density lipoprotein and thrombus precursor protein with acute cerebral infarction

Asymmetric Dimethyarginine As Marker And Mediator In Ischemic Stroke

Correlation between ABCD2 score and magnetic resonance diffusion-weighted imaging in patients with transient ischemic attack

Correction: Association of Dimethylarginines and Mediators of Inflammation after Acute Ischemic Stroke

High Plasma Dimethylarginine Levels Are Associated with Adverse Clinical Outcome after Stroke.

The ABCD2 Score is Better for Stroke Risk Prediction after Anterior Circulation TIA Compared to Posterior Circulation TIA.

Serum Concentrations of Adiponectin and Interlukin-10(IL-10) in Patients with Acute Cerebral Infarction

Correlation Between ABCD, ABCD2 Scores and Craniocervical Artery Stenosis in Patients with Transient Ischemic Attack.

The Evaluation and Improvement of Early Stroke Prediction after Transient Ischemic Attack

Value of Serum Adiponectin Combined with ABCD2 in Predicting Cerebral Infarction Among Patients with Acute Isolated Vertigo

Increased cerebrospinal fluid concentrations of asymmetric dimethylarginine correlate with adverse clinical outcome in subarachnoid hemorrhage patients.

Comparison and improvement of in predicting the short-term prognosis of transient ischemic attack between ABCD and ABCD2 scores

Prediction of Infarct Lesion Volumes by Processing Magnetic Resonance Apparent Diffusion Coefficient Maps in Patients with Acute Ischemic Stroke

Duration of symptom and ABCD2 score as predictors of risk of early recurrent events after transient ischemic attack: a hospital-based case series study

ABCD 2 Score May Discriminate Minor Stroke from TIA on Patient Admission

Predictive value of MRA, DWI and ABCD2 score for secondary cerebral infarction after transient ischemic attack